Retrospective Analysis of Bevacizumab in Combination with Fotemustine in Chinese Patients with Recurrent Glioblastoma Multiforme

Table 1

Patient characteristics.

Characteristics	Population ()
Gender, (%)
Female	65 (36.9)
Male	111 (63.1)
Median age, years (range)	56.5 (22–74)
KPS score, (%)
≥70	98 (55.7)
<70	78 (44.3)
Steroid use, (%)
No	51 (29.0)
Yes	125 (71.0)
Type of first surgery, (%)
Biopsy	17 (9.7)
Partial resection	66 (37.5)
Subtotal/total resection	93 (52.8)
MGMT status
Unmethylated	72 (40.9)
Methylated	65 (36.9)
Not evaluable	39 (22.2)
Time from original diagnosis (months)	12 (3–122)
Second surgery before treatment
No	144 (81.8)
Yes	32 (18.2)
Initial tumor size (mm^2)	1800 (200–5300)
Initial maximum diameter (mm)	60 (15–105)